<DOC>
	<DOC>NCT01476943</DOC>
	<brief_summary>The primary purpose is to describe the pattern of Belatacept use at the time of transplant and up to three years post-transplantation for all Belatacept treated patients.</brief_summary>
	<brief_title>Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study</brief_title>
	<detailed_description>Time Perspective: Prospective design, Retrospective data collection and analysis</detailed_description>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Patients who received solid organ transplantation during study period in one of the transplant centers involved in CTS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>